お知らせ

原著論文・総説・論評 等

  • Hijikata Y, Yokoyama K, Tani K, Matsubara Y, Lim LA, Shimizu E, Yamaguchi R, Yotusuyanagi H, Imoto S, Miyano S, Tojo A. Successful clinical sequencing in an elderly patient with refractory Sézary syndrome: a case report. JCO Precision Oncol. 2020 May; 4.534-60.
  • Hijikata, Y. Matsubara, Y. Ota, Y. Lim, LA. Tani, K. Hirata, Y. Yotsuyanagi, H. Safe Use of Nivolumab in a Patient with Epipharyngeal Carcinoma and Preexisting Ulcerative Colitis: A Histologically Proven Case Report. Intern Med. 2020 Apr 15;59 (8):1105-1109.
  • Ito T, Hanafusa N, Iwase S, Noiri E, Nangaku M, Nakagawa K, Miyagawa K. Ascitic IL‐10 concentration predicts prognosis of the patients undergoing Cell‐Free and Concentrated Ascites Reinfusion Therapy (CART). Ther Apher Dial. 2020 Feb;24 (1):90-95.
  • Murahashi M, Tsuruta T, Yamada K, Hijikata Y, Ogata H, Kishimoto J, Yoshimura S, Hikichi T, Nakanishi Y, Tani K.Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer. Anticancer Res. 2021 Mar;41 (3):1485-1496
  • Matsubara, Y. Lim, LA. Hijikata, Y. Hirata, Y. Yotsuyanagi, H. Embolization coil migration in the stomach and spontaneous excretion: a case report and review of the literature. Radiol Case Rep. 2020 May 26;15 (7):1018-1022. 
  • Nishiyama, N., Matsuda, Y., Fujiwara, N. Ariyoshi, K., Oyamada, S., Narita, K., Ishii, R., Iwase, S. The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02). BMC Palliat Care. 2020 Oct 22;19 (1):164.
  • Matsubara Y, Kobayashi M, Hijikata Y, Ota Y, Hirata,Y, Lim LA, Yotsuyanagi H, Tojo A.  Gastrointestinal lesion in adult-onset Langerhans cell histiocytosis. 2020 Nov;25 (11):1945-1950.
  • Ishitani K, Isoai A, Ito T, Sugiyama H, Arakawa A, Yamada Y, Onodera H, Kobayashi R, Torii N, Soneda N, Matsuno Y, Utsugisawa T, Kato M, Hanafusa N. Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study. Int J Clin Oncol. 2021 Jun; 26(6):1130-1138.
  • Arakawa S, Amano K, Oyamada S, Maeda I, Ishiki H, Miura T, Hatano Y, Shirado Naito A, Sato M, Ito T, Kosugi K, Miyake S, Morita T, Mori M,.Effects of parenteral nutrition and hydration on survival in advanced cancer patients with malignant bowel obstruction: Secondary analysis of a multicenter prospective cohort study. Support Care Cancer. 2021 Jun 10. Online ahead of print.
  • Nishijima K, Kizawa Y, Yamauchi T, Odagiri T, Ito T, Kaneishi K, Shimizu K, Morita T, Mori M. Prevalence and associated factors of orphan symptoms in advanced cancer patients: a multicenter observational study. Support Care Cancer. 2021 Mar 16. Online ahead of print.
  • Higashibata T, Hisanaga T, Hagiwara S, Shimokawa M, Yabuki R, Odagiri T, Ito T, Kamura R, Maeda I, Kosugi K, Mori M, Morita T, Tsuneto S, Hamano J. Differences among institutions in the prevalence of and indications for urinary catheterization of advanced cancer patients at palliative care units: A multicenter prospective cohort study (EASED). Palliat Med. 2021 Apr;35 (4):799-805.  
  • Ito T, Yokomichi N, Ishiki H, Kawaguchi T, Masuda K, Tsukuura H, Funaki H, Suzuki K, Oya K, Nakagawa J, Mori M, Yamaguchi T. Optimal paracentesis volume for terminally ill cancer patients with ascites. J Pain Symptom Manage. 2021 Apr. Online ahead of print.